S Hunter Dunn1, Shari S Rogal2, Marissa M Maier3, Maggie Chartier4, Timothy R Morgan5, Lauren A Beste6. 1. Department of Medicine, University of Washington, 1959 NE Pacific Street, Seattle, WA, 98195, USA. Shdunn@uw.edu. 2. Departments of Surgery and Medicine, VA Pittsburgh Healthcare System, 1 University Drive, Pittsburgh, PA, 15240, USA. 3. Division of Infectious Diseases, VA Portland Health Care System, 3710 SW US Veterans Hospital Road, Portland, OR, 97239, USA. 4. HIV, Hepatitis, and Related Conditions Programs Office of Specialty Care Services, U.S. Department of Veterans Affairs, 810 Vermont Avenue NW, Washington, DC, 20571, USA. 5. Gastroenterology Section, VA Long Beach Healthcare System, 5901 E. Seventh Street, Long Beach, CA, 90822, USA. 6. General Medicine Service, VA Puget Sound Health Care System, 1660 S Columbian Way, Seattle, WA, 98108, USA.
Abstract
BACKGROUND: The Veterans Health Administration (VHA) provides care to the one of the largest cohorts of patients with advanced liver disease (ALD) in the USA. AIMS: We performed a national survey to assess system-wide strengths and barriers to care for Veterans with ALD in this national integrated healthcare setting. METHODS: A 52-item survey was developed to assess access and barriers to care in Veterans with ALD. The survey was distributed to all VHA medical centers in 2015. Results were analyzed using descriptive statistics. RESULTS: One hundred and fifty-three sites responded to this survey. Multidisciplinary services were available on-site at > 80% of sites. Ninety-five percent of sites had mental health and addictions treatment available, with 14% co-locating these services within the liver clinic. Few sites (< 25%) provided pharmacologic treatment for alcohol use disorder in primary care or hepatology settings. Seventy-two percent of sites reported at least one barrier to liver-related care. Of the sites reporting at least one barrier, 53% reported barriers to liver transplant referral, citing complex processes and lack of staff/resources to coordinate referrals. Palliative care was widely available, but 61% of sites reported referring < 25% of their patients with ALD for palliative services. CONCLUSION: Multidisciplinary services for Veterans with ALD are widely available at VHA sites, though barriers to optimal care remain. Opportunities for improvement include the expansion of providers with hepatology expertise, integrating pharmacotherapy for alcohol use disorder into hepatology and primary care, streamlining the transplant referral process, and expanding palliative care referrals for patients with ALD.
BACKGROUND: The Veterans Health Administration (VHA) provides care to the one of the largest cohorts of patients with advanced liver disease (ALD) in the USA. AIMS: We performed a national survey to assess system-wide strengths and barriers to care for Veterans with ALD in this national integrated healthcare setting. METHODS: A 52-item survey was developed to assess access and barriers to care in Veterans with ALD. The survey was distributed to all VHA medical centers in 2015. Results were analyzed using descriptive statistics. RESULTS: One hundred and fifty-three sites responded to this survey. Multidisciplinary services were available on-site at > 80% of sites. Ninety-five percent of sites had mental health and addictions treatment available, with 14% co-locating these services within the liver clinic. Few sites (< 25%) provided pharmacologic treatment for alcohol use disorder in primary care or hepatology settings. Seventy-two percent of sites reported at least one barrier to liver-related care. Of the sites reporting at least one barrier, 53% reported barriers to liver transplant referral, citing complex processes and lack of staff/resources to coordinate referrals. Palliative care was widely available, but 61% of sites reported referring < 25% of their patients with ALD for palliative services. CONCLUSION: Multidisciplinary services for Veterans with ALD are widely available at VHA sites, though barriers to optimal care remain. Opportunities for improvement include the expansion of providers with hepatology expertise, integrating pharmacotherapy for alcohol use disorder into hepatology and primary care, streamlining the transplant referral process, and expanding palliative care referrals for patients with ALD.
Entities:
Keywords:
Gastroenterology; Health care; Liver cirrhosis; Quality assurance; Surveys and questionnaires; United States Department of Veterans Affairs; Veterans Health
Authors: Pamela S Belperio; Maggie Chartier; Rachel I Gonzalez; Angela M Park; David B Ross; Tim R Morgan; Lisa I Backus Journal: Infect Dis Clin North Am Date: 2018-06 Impact factor: 5.982
Authors: Lauren A Beste; Thomas J Glorioso; P Michael Ho; David H Au; Susan R Kirsh; Jeffrey Todd-Stenberg; Michael F Chang; Jason A Dominitz; Anna E Barón; David Ross Journal: Am J Med Date: 2016-12-18 Impact factor: 4.965
Authors: Lauren A Beste; Steven L Leipertz; Pamela K Green; Jason A Dominitz; David Ross; George N Ioannou Journal: Gastroenterology Date: 2015-08-05 Impact factor: 22.682
Authors: K Ikeda; S Saitoh; Y Suzuki; M Kobayashi; A Tsubota; I Koida; Y Arase; M Fukuda; K Chayama; N Murashima; H Kumada Journal: J Hepatol Date: 1998-06 Impact factor: 25.083
Authors: Elizabeth S Aby; Adam C Winters; Jonathan Lin; Aileen Bui; Jenna Kawamoto; Matthew B Goetz; Debika Bhattacharya; Joseph R Pisegna; Folasade P May; Arpan A Patel; Jihane N Benhammou Journal: Hepatol Commun Date: 2020-04-24